patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · protein
angiotensin II
Phase 1updated 2mo agoby Platform Therapeutics Inc🔗 ChEMBL
Phase 1community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 6 investigational indications.
targets
Type-1 angiotensin II receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that